JAGX vs MSCI · rev $1.2M vs P/E 37, rev $1.72B
Jaguar Animal Health Inc (JAGX) versus MSCI Inc (MSCI) — a side-by-side from cached financials, not a winner call.
Jaguar Animal Health Inc (JAGX) is a biotechnology company listed on NASDAQ.
MSCI Inc (MSCI) is a financial data & stock exchanges company listed on US.
Latest reported JAGX revenue for 2026-06-30 was $1.2M. Net income was -$12.8M. Revenue was down 94.0% from 2026-03-31 to 2026-06-30. JAGX currently screens at market cap $1.7M.
Latest reported MSCI revenue for 2026-06-30 was $1.72B. Net income was $748.0M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
JAGX currently screens at market cap $1.7M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
Not investment advice. Open the JAGX and MSCI stock pages for the full models.
Not investment advice.